Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic profiling of cancer with circulating tumor DNA analysis.

Journal of genetics and genomics = Yi chuan xue bao - 20 Feb 2018

Lu Ling, Bi Junqin, Bao Liming

Abstract excerpt

Circulating cell-free tumor DNA (ctDNA) in the blood is DNA released from apoptotic, circulating, and living tumor cells. ctDNA is about 140 nt in length and has a half-life of about 1.5 h. ctDNA analysis provides a noninvasive means to assess the genetic profile of cancer in real time. With the advent of molecular technologies, including digital PCR and massively parallel sequencing (MPS), ctDNA analysis has...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Biomarkers, Tumor
Share to Biopsy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cancer Genomics and Diagnostics

Share to Circulating Tumor DNA

Share to Early Detection of Cancer

Share to Mutation

Share to Neoplasms

Source

Identifiers

PMID: 29502957
DOI: 10.1016/j.jgg.2017.11.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic profiling of cancer with circulating tumor DNA analysis.PMID 29502957Read ↗

Revolution of Circulating Tumor DNA: From Bench Innovations to Bedside ImplementationsSemantic proximity Read ↗

Detection of Circulating Tumor DNA in Plasma Using Targeted Sequencing.Semantic proximity Read ↗

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.Semantic proximity Read ↗

Circulating Tumor DNA as Biomarkers for Cancer DetectionSemantic proximity Read ↗

Decoding the Dynamics of Circulating Tumor DNA in Liquid BiopsiesSemantic proximity Read ↗

Circulating tumor DNA in blood: Future genomic biomarkers for cancer detectionSemantic proximity Read ↗

Toward liquid biopsies in cancer treatment: application of circulating tumor DNASemantic proximity Read ↗

Circulating tumor DNA-From bench to bedside.Semantic proximity Read ↗

Circulating tumor DNA: current challenges for clinical utility.Semantic proximity Read ↗

Clinical Circulating Tumor DNA Testing for Precision Oncology.Semantic proximity Read ↗

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.Semantic proximity Read ↗

Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer DetectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.